GlobalData on MSN9h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Reuters15h
Asia Pacific
Philippines President Ferdinand Marcos Jr directed authorities on Friday to stock up on food and other supplies in advance as Typhoon Man-yi threatened to hit the capital region. Asia ...